Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer
Clinical trial NCT07635290 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07635290
- Sponsor
- West China Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-03
- Primary completion
- 2027-06-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.